Every earnings call for WOCKPHARMA — management tone, guidance, KPIs and promise tracking, quarter by quarter.
WOCKPHARMA · 3 transcripts · Healthcare · latest Q4 FY26Wockhardt has 3 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Revenue ₹3,373 cr; EBITDA ₹630 cr (+51% YoY); EBITDA Margin 18.6%. Top line revenue reached INR 3,373 crores for FY26.
Read full transcript & analysisRevenue ₹3,033 cr (+5% YoY); EBITDA ₹418 cr (+67% YoY); EBITDA Margin 14%. Annual Revenue reached ₹3,033 crores, representing a 5% YoY growth.
Read full transcript & analysisRevenue ₹699 cr; EBITDA ₹59 cr. Revenue grew to ₹699 crores in Q3 FY23, representing a 20% increase over Q1 FY23.
Read full transcript & analysis